Exo

Exo Announces Lead Program, Targeting TANK Binding Kinase 1 (TBK1), for the Treatment of Autoimmune Diseases

Retrieved on: 
Tuesday, May 23, 2023
Health, Other Science, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Inflammation, Tufts University Graduate School of Biomedical Sciences, Therapy, Lupus, Head, Infectious Diseases Institute, Inflammation Research, Multimedia, SLE, Biomarker, Doctor of Philosophy, Harvard Medical School, Exo, Santa Clara University, Patient, Autoimmune disease, TBK1, Biomedical sciences, AGS, Pharmaceutical industry, Sanofi, Immunology, Biology

Dr Joseph will be responsible for leading biology, translational and pre-clinical work for Exo’s programs.

Key Points: 
  • Dr Joseph will be responsible for leading biology, translational and pre-clinical work for Exo’s programs.
  • This press release features multimedia.
  • She also previously served as Head of Translational research at Kiniksa Pharmaceuticals, where she was responsible for the design and implementation of translational research strategy for the company.
  • Exo intends to declare a development candidate in their lead program later this year and enter the clinic within the next two years.

Exo Works™ Achieves HITRUST and SOC 2 Type II Certifications, Meeting Highest Bar for Patient Data Security

Retrieved on: 
Tuesday, April 25, 2023
Data Management, Health, Security, Medical Devices, Technology, Software, Radiology, Ketan, Cloud, Accountability Act, Smartphone, EMR, Health Insurance Portability and Accountability Act, Web browser, SOC, Confidentiality, POCUS, HITRUST, Organization, Exo, Physician, Risk, Certification, PACS, HIPAA, Medical device

These achievements provide additional assurances that Exo sufficiently manages risk, improves security posture and meets compliance requirements for protecting patient data.

Key Points: 
  • These achievements provide additional assurances that Exo sufficiently manages risk, improves security posture and meets compliance requirements for protecting patient data.
  • HITRUST Risk-based, 2-year Certified status validates that Exo Works has met key regulations and is appropriately managing risk according to the framework of controls put forth by HITRUST.
  • By achieving it, Exo customers can be assured that Exo Works is meeting the highest standards for data security.
  • “Achieving the HITRUST Certification and successfully completing the SOC 2 Type II certification places Exo in an elite group of organizations worldwide,” said Ketan Patel, Head of Security & Cloud Operations at Exo.

Odyssey Marine Exploration Announces Reduction of Debt & Potential Dilution That Is Accretive to Shareholders; Provides Updates on Company Projects and Progress

Retrieved on: 
Friday, March 10, 2023
Professional Services, Other Natural Resources, Maritime, Mining, Minerals, Transport, Natural Resources, Finance, Odyssey, Environment, NAFTA, Research, Technical report, ROV, Nature, Odex's actions against file-sharing, Mineral, Cook, SPA, Note, ICSID, OMEX, AHMSA, CIC, Cook Islands, Odyssey Marine Exploration, Federal courts of Switzerland, SEMARNAT, Exo, Cryptocurrency, Security (finance), Whaling, Uranium mining

Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), a global subsea mineral exploration and development company, has reached an agreement with Altos Hornos de México, S.A.B.

Key Points: 
  • Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), a global subsea mineral exploration and development company, has reached an agreement with Altos Hornos de México, S.A.B.
  • Taking into consideration the newly issued $14 million in notes, the net reduction in indebtedness (principal and interest) is $17.45 million.
  • Odyssey conducted significant offshore exploration, sampling, and environmental testing and, in 2014, completed an NI 43-101 compliant technical report.
  • Odyssey has invested more than $4.5 million of in-kind services to the project and cash financing of more than $1.5M to date.

Arden Group Selects View Smart Windows for Mixed-Use Residential Development at 4650 Broadway

Retrieved on: 
Thursday, January 26, 2023
Health, Research, Handel Architects, Building at 1929–1931 Sherman Avenue, Lacos Land Co v. Arden Group Inc, Eye, Tenant, Sleep, ITC, Fort Tryon Park, GLARE, ESG, Arden, Tax credit, Headache, Exo, View, Inc., Heating, ventilation, and air conditioning, Television, Tunnel

NEW YORK and MILPITAS, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Arden Group (“Arden”), a leading U.S. middle-market real estate fund manager, announced that its new mixed-use building will feature smart windows from View, Inc. (Nasdaq: VIEW) (“View”), the leader in smart building platforms and smart glass. The 20-story building is under development at 4650 Broadway in the Inwood section of Manhattan.

Key Points: 
  • View Smart Windows are being installed throughout the building as a premium amenity for its tenants, supporting Arden’s commitment to ESG initiatives and tenant wellbeing.
  • View Smart Windows automatically adjust in response to the sun to maximize access to natural light and views of the outdoors while minimizing heat and glare.
  • “Arden is proud to offer our residents an elevated and differentiated living experience by incorporating View Smart Windows at our new 4650 Broadway property,” said Craig A. Spencer, Chairman and CEO of Arden Group.
  • 4650 Broadway joins the growing number of View Smart Windows’ multi-family properties, which include Parque Kirkland in Seattle, Washington; Exo in Reston, VA; Bower in Boston, MA; and Sven in Queens, NY.

Exo® Wins 2023 BIG Innovation Award for Exo Works™

Retrieved on: 
Wednesday, January 11, 2023
Health, Medical Devices, Technology, Audio, Video, Software, Radiology, Artificial Intelligence, POCUS, Documentation, Face, Caregiver, PACS, Smartphone, Web browser, Patient, Frustration, Physician, Medical imaging, Medicine, Exo

Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced it has been named a winner in the 2023 BIG Innovation Awards , presented by the Business Intelligence Group.

Key Points: 
  • Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced it has been named a winner in the 2023 BIG Innovation Awards , presented by the Business Intelligence Group.
  • Exo launched Exo Works in March 2022 to make it easy to address common ultrasound challenges.
  • We designed Exo Works with physicians and patients at the forefront, so that exam documentation is now a breeze,” said Sandeep Akkaraju, CEO and co-founder of Exo.
  • “The entire Exo team is honored to be recognized by the BIG Innovation Awards as we continue our mission to bring medical imaging everywhere.”
    To learn more about Exo Works, click here .

Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair

Retrieved on: 
Wednesday, January 4, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, IPO, Babson College, Vesicle (biology and chemistry), Harvard Medical School, California Institute for Quantitative Biosciences, Therapy, Vertex, Corporation, Interim, Alnylam Pharmaceuticals, Vice president, MBA, Acquisition, Ávila, University, University of Colorado Denver School of Public Affairs, Exo, Nagesh, Doctor of Philosophy, Chemistry, Neuroscience, Biology

Exo Therapeutics, Inc. , a company pioneering the use of enzymatic exosites to address intractable drug targets, today announced the appointment of Nagesh Mahanthappa, PhD, to Executive Chair.

Key Points: 
  • Exo Therapeutics, Inc. , a company pioneering the use of enzymatic exosites to address intractable drug targets, today announced the appointment of Nagesh Mahanthappa, PhD, to Executive Chair.
  • “The ExoSight™ platform has tremendous potential to be applied across a wide range of diseases and therapeutic targets,” said Dr. Mahanthappa.
  • “It’s an honor to join Exo as Executive Chair at this exciting time and guide the advancement of our best- and first-in-class programs towards the clinic.”
    Dr. Mahanthappa has served on Exo’s Board of Directors since March 2021 before being appointed Executive Chair.
  • “We are thrilled that Nagesh is stepping into the role of Executive Chair at this important time in the company’s development,” said Dorothy Lou Bailey, COO and Interim President at Exo.

Exo® Announces New Headquarters to Accommodate Company’s Growth

Retrieved on: 
Tuesday, November 29, 2022
Medical Devices, Health, Technology, Health Technology, Software, Artificial Intelligence, Software, Growth, Culture, San Francisco Bay Area, Heel, Restaurant, Artificial intelligence, Research, Acquisition, Medical imaging, Exo

Exo (pronounced echo), a pioneering medical imaging software and devices company, today announced it has relocated its headquarters to 4201 Burton Drive in Santa Clara, California.

Key Points: 
  • Exo (pronounced echo), a pioneering medical imaging software and devices company, today announced it has relocated its headquarters to 4201 Burton Drive in Santa Clara, California.
  • Exos new headquarters occupy 50,000 square feet, double the size of the companys previous space.
  • In addition to supporting medical imaging innovation, Exos new headquarters is now centrally located to more attractions and amenities.
  • For those interested in joining the growing Exo team, visit the companys careers page.

Exo® CFO Lori Munoz Wins Stevie Award for Women in Business

Retrieved on: 
Tuesday, November 22, 2022
Health Technology, Health, Medical Devices, Pura, Woman, BlackRock, Gold, AI, Health care, Stevie Awards, Acquisition, Intel Capital, Intelligence, Customer service, Artificial intelligence, Silver, Ecosystem, Magnetar Capital, Organization, International business, Workplace, Sports broadcasting contracts in Middle East & North Africa, American Business Women's Association, Marquess, Medical imaging, Medicine, Exo, Health Technology, Health, Medical Devices

Exo (pronounced echo), a pioneering medical imaging software and devices company, today announced its Chief Financial Officer, Lori Munoz, has been recognized with a Bronze Stevie Award in the Healthcare category of the 2022 Stevie Awards for Women in Business .

Key Points: 
  • Exo (pronounced echo), a pioneering medical imaging software and devices company, today announced its Chief Financial Officer, Lori Munoz, has been recognized with a Bronze Stevie Award in the Healthcare category of the 2022 Stevie Awards for Women in Business .
  • Since joining Exo in July 2020, Munoz has played a pivotal role in supporting Exos growth spearheading key fundraising and M&A efforts.
  • The Stevie Awards for Women in Business honor women executives, entrepreneurs, employees, and the companies they run worldwide.
  • Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards, The International Business Awards, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service.

Co-Founder of Exo® and “Father of Sensors” Technology, Dr. Janusz Bryzek, Passes Away

Retrieved on: 
Tuesday, November 15, 2022
Software, Technology, Health, Medical Devices, MEMS, Visa requirements for Polish citizens, North, Authoritarianism, PMUT, Breeding, Entrepreneurship, Patent, Former, Traction, Multimedia, Death, Human, Health equity, Attitude, Education, VC, Philosophy, Artificial intelligence, Family, Sensor, Silicon, Book, Engineering, Television, Management, Exo

View the full release here: https://www.businesswire.com/news/home/20221115005427/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221115005427/en/
    Januszs passing leaves me without words, shared Sandeep Akkaraju, CEO and Co-Founder of Exo.
  • Janusz lived by a philosophy of abundance, achieving this through the exponential power of technological innovations.
  • Janusz believed true equity depends upon humans who are committed to enacting this exponential change.
  • As with all his startups, Exo employees became his family, added John Kokulis, Co-Founder and Former Chief Financial Officer of Exo.

Exo® Named a Most Innovative Company by the International Business Awards

Retrieved on: 
Monday, August 15, 2022
Technology, Health, Artificial Intelligence, Medical Devices, Stevie Awards, Intelligence, CEO, Sports broadcasting contracts in Middle East & North Africa, Diagnosis, Ecosystem, Technology, Customer service, Workplace, Facebook, American Business Women's Association, Caregiver, International Business College (Fort Wayne, Indiana), Instagram, Twitter, Acquisition, Bronze, Artificial intelligence, LinkedIn, Woman, Organization, Medical imaging, Film, Exo

Exo (pronounced echo), a pioneering health information and medical devices company, today announced it has been honored with a Bronze Stevie Award in the Most Innovative Company of the Year category in the 19th annual International Business Awards .

Key Points: 
  • Exo (pronounced echo), a pioneering health information and medical devices company, today announced it has been honored with a Bronze Stevie Award in the Most Innovative Company of the Year category in the 19th annual International Business Awards .
  • In March 2022, the company released Exo Works , an intuitive point-of-care ultrasound workflow solution that significantly reduces caregivers time documenting patient data.
  • The International Business Awards are the worlds premier business awards program.
  • Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, and the Stevie Awards for Sales & Customer Service.